Navigation Links
VAP(R) Cholesterol Test From Atherotech Covers an Additional 9 Million of Florida Insured
Date:8/12/2008

Comprehensive Cholesterol Test Can Help Identify Patients At Risk of Heart

Disease and Diabetes

BIRMINGHAM, Ala., Aug. 12 /PRNewswire/ -- Atherotech, Inc., a cardio-diagnostic company, today announced that the largest private insurers in Florida as well as Medicare, Medicaid and the Federal Employees Health Benefits (FEHB) Program now cover the VAP(R) (Vertical Auto Profile) Test, the most comprehensive cholesterol test available. That means 9 million more insured lives in Florida now have insurance coverage for the VAP Test, which finds a far greater number of people at risk than the standard cholesterol test.

"The routine lipid panel, which measures total cholesterol, HDL, and triglycerides and calculates LDL, has been shown to have a 40-percent predictive value for coronary heart disease (CHD)," said Paul Ziajka, M.D., Ph.D., director of The Florida Lipid Institute in Winter Park, Fla. "The VAP Test provides twice the predictive ability in indentifying CHD risk compared with traditional lipid panels."

People with a family history or an existing condition of diabetes, high blood pressure or heart disease -- or who are already taking cholesterol lowering medication -- are candidates for the comprehensive VAP Test.

"This is a more advanced blood test that can far more accurately gauge your risk of heart disease," said Michael Ozner, M.D., F.A.C.C., of the Cardiovascular Prevention Institute of South Florida, and author of The Miami Mediterranean Diet. "The VAP Test not only offers a comprehensive assessment of cardiovascular risk, but also supplies vital information that can help you and your doctor formulate a customized disease-prevention program and measure its progress over time. This powerful diagnostic tool can help people take the steps necessary to avoid preventable health catastrophes -- like heart attack and stroke."

The VAP (Vertical Auto Profile) Test is the most accurate and comprehens
'/>"/>

SOURCE Atherotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VAP(R) Cholesterol Test Bolsters Biophysical(R) Health Assessment
2. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
3. New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl)
4. Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
5. VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
6. Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy
7. Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination
8. Phase 1 Studies Show Promise of QuatRxs Novel Compound, Sobetirome, for Lowering LDL Cholesterol Levels
9. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
10. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
11. Atherotech to Exhibit the VAP Test at Internal Medicine 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 21, 2014 Shimadzu Scientific ... LC/MS/MS data tool for the pain management and clinical ... data processing and review by allowing users to highlight ... clinicians. , QuantAnalytics allows analysts to filter results ... expedites data processing by eliminating the need to sift ...
(Date:10/22/2014)... UAE (PRWEB) October 22, 2014 Grace ... science and healthcare projects, announces the addition of ... DCH to its advisory team. Dr. Siddiqui will provide ... , A graduate of University College Medical ... subsequently degreed in medicine in 2001. With further certification ...
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" ... announced next steps for its Oral Amphotericin B ... its in vitro work involving samples ... now plans to complete pre clinical studies and ... Phase 1A clinical trial, utilizing approximately $700,000 of ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 The ... (Medication Dispensing Systems, Packaging and Labeling Systems, Table-top ... Automation) - Global Forecasts & Trends to 2019” ... and opportunities in North America, Europe, Asia-Pacific, and ... 101 market tables and 30 figures spread through ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
... QUEBEC CITY, June 3, 2011 Asmacure ... of nicotinic receptor agonists for the treatment of asthma ... has been appointed as chief executive officer.  With a ... the company as it progresses its lead compound, a ...
... /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO ... results for the fourth quarter and full year of fiscal ... in the US.   The Company will hold ... 13, 2011 to discuss its financial performance and give a ...
... Pharmaceuticals, Inc. (Nasdaq: ANTH ), today announced ... common stock in an underwritten public offering.  The Company expects ... to an additional 15% of the shares of common stock ...  Citi and Leerink Swann LLC are acting as joint book-running ...
Cached Biology Technology:Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 2Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 3China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results 2Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/16/2014)... Mary,s Virginia Institute of Marine Science have received ... Agency to identify the streams and wetlands most ... to help local governments and citizens conserve these ... a dataset of tidal-marsh observations first gathered by ... historical baseline can today,s researchers accurately map the ...
(Date:10/16/2014)... causes severe respiratory tract infections and worldwide claims ... at VIB and Ghent University have succeeded in ... common virus infection. , Xavier Saelens (VIB/UGent): ... the way for the development of a novel ... causes suffering in numerous small children and elderly ...
Breaking Biology News(10 mins):Sperm wars 2EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3New perspectives for development of an RSV vaccine 2
... In the 1980s, Harald zur Hausen and his co-workers discovered ... Scientists soon found out how these pathogens cause cells to ... viral proteins E6 and E7. Both proteins switch off different ... Dr. Frank Rsl and his co-workers at DKFZ have now ...
... message: Preliminary Press Conference Topics ... of Sciences museum Attention PIOs: Sending Press Releases ... deadline 10 December News Media registration information ... 7 December Who,s coming For important ...
... in warmer water, according to an intriguing new study suggesting ... Experiments with two species of young damselfish on Australia,s Great ... reef fish are either consistently timid, or consistently bold, and ... temperatures rise. A slight lift of just one or ...
Cached Biology News:Papillomavirus silences innate immune response 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Fish with attitude: Some like it hot 2
... 2800mL wide mouth PYREX Fernbach-style culture flask is ... area to volume ratio. It can also be ... bottom outside edges to achieve maximal oxygen transfer ... 63mm I.D. and accepts cotton plugs or No. ...
... FRT-PGK-gb2-neo-FRT template is designed to ... cells. The FRT-PGK-gb2-neo-FRT template encodes the ... promoter (gb2) for expression of kanamycin resistance ... promoter (PGK) for expression of neomycin resistance ...
These are replacement caps for No. CLS6980 5mm PYREX NMR tubes. Proper method to remove caps is to slice them from the tube. Caps come in eight assorted/mixed colors. Packed in bags of 100....
... inch long PYREX NMR tubes are made from ... valves, and vacuum racks. They are designed for ... 500MHz. They have an O.D. of 4.97 + ... These NMR tubes can be used with the ...
Biology Products: